Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294356 · ClinicalTrials.gov registry record · NA
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
A NA study of Smoking, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 5
- Study locations
NCT03294356: Completed NA study of Smoking, sponsored by RAI Services Company.
NCT03294356 is a NA study of Smoking that has completed, run by RAI Services Company. The registered enrollment target is 210 participants, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (54% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03294356, a NA study of Smoking, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 5
- Study locations
Study Summary
To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of five different marketed electronic cigarettes, or one combustible cigarette (CC). Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.
Primary Outcome
To assess nicotine uptake with the start of a 10-minute ad libitum Investigational Product (IP) use period.
Conditions Studied
Interventions
- OTHER FT210771
- OTHER FT210751
- OTHER 6T30134157764
- OTHER G41A7C071
- OTHER M011161212
Study Locations (5)
Arizona
- Clinical Research Consortium (CRC) - Tempe
Kentucky
- Central Kentucky Research Associates (CKRA) - Lexington
Missouri
- St. Louis Clinical Trials (SLCT) - St Louis
Ohio
- Midwest Clinical Research (MCRC) - Dayton
Tennessee
- New Orleans Center for Clinical Research (NOCCR) - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2017-09-13 |
| Est. Completion | 2017-11-02 |
| Phase | NA |
What the finished NCT03294356 record still lists
NCT03294356 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 5 interventions - of which FT210771 is the first listed.
NCT03294356 lists 5 locations in 5 states (Arizona, Kentucky, Missouri).
Frequently Asked Questions
What is clinical trial NCT03294356 about?
NCT03294356 is a clinical study titled "CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes". To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of five different marketed electronic cigarettes, or one combustible cigarette (CC). Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) ...
What is the current status of trial NCT03294356?
This trial is currently completed. It is a NA study. The enrollment target is 210 participants. The study started on 2017-09-13. Estimated completion is 2017-11-02.
What conditions does trial NCT03294356 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT03294356?
The interventions under investigation include: FT210771 (OTHER), FT210751 (OTHER), 6T30134157764 (OTHER), G41A7C071 (OTHER), M011161212 (OTHER).
Who is sponsoring clinical trial NCT03294356?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03294356 being conducted?
This trial has 5 study locations across Arizona, Kentucky, Missouri, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03294356's enrollment target sits among peer trials
210 55th of 123 higher than 68 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI